Search

Your search keyword '"Daniel C. Javitt"' showing total 253 results

Search Constraints

Start Over You searched for: Author "Daniel C. Javitt" Remove constraint Author: "Daniel C. Javitt" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
253 results on '"Daniel C. Javitt"'

Search Results

1. Network-level mechanisms underlying effects of transcranial direct current stimulation (tDCS) on visuomotor learning in schizophrenia

2. NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial

3. Disrupted third visual pathway function in schizophrenia: Evidence from real and implied motion processing

4. Disruption of early visual processing in amyloid-positive healthy individuals and mild cognitive impairment

5. Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder

6. Disease-Specific Contribution of Pulvinar Dysfunction to Impaired Emotion Recognition in Schizophrenia

8. Deficits in Pre-attentive Processing of Spatial Location and Negative Symptoms in Subjects at Clinical High Risk for Schizophrenia

9. Network-level mechanisms underlying effects of transcranial direct current stimulation (tDCS) on visuomotor learning

10. Multimodal Computational Modeling of Visual Object Recognition Deficits but Intact Repetition Priming in Schizophrenia

11. Translational neurophysiological biomarkers of N-methyl-d-aspartate receptor dysfunction in serine racemase knockout mice

12. The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures

13. Relationships between Diffusion Tensor Imaging and Resting State Functional Connectivity in Patients with Schizophrenia and Healthy Controls: A Preliminary Study

14. Sensory and cross-network contributions to response inhibition in patients with schizophrenia

15. Deficits and compensation: Attentional control cortical networks in schizophrenia

16. A multicenter study of ketamine effects on functional connectivity: Large scale network relationships, hubs and symptom mechanisms

17. Meeting overview: Sensory perception and schizophrenia, Lausanne, Switzerland June 31–July 1, 2014

18. Cognitive Impairment Associated with Schizophrenia: From Pathophysiology to Treatment

19. Efficacy of Transcranial Direct Current Stimulation to Improve Insight in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Randomized Controlled Trials

20. Computational modeling of excitatory/inhibitory balance impairments in schizophrenia

21. Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058

22. Neurophysiological, Oculomotor, and Computational Modeling of Impaired Reading Ability in Schizophrenia

23. What you see is what you get: visual scanning failures of naturalistic social scenes in schizophrenia

24. A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology

26. Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder

27. The road not taken: disconnection of a human-unique cortical pathway in schizophrenia and its effects on naturalistic social cognition

28. Differential Patterns of Visual Sensory Alteration Underlying Face Emotion Recognition Impairment and Motion Perception Deficits in Schizophrenia and Autism Spectrum Disorder

29. Bimodal distribution of tone-matching deficits indicates discrete pathophysiological entities within the syndrome of schizophrenia

30. Disease-specific contribution of pulvinar dysfunction to impaired emotion recognition in schizophrenia

31. Deficits in Pre-attentive Processing of Spatial Location and Negative Symptoms in Subjects at Clinical High Risk for Schizophrenia

32. Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers

33. Comparison of cortical network effects of high-definition and conventional tDCS during visuomotor processing

34. Translational neurophysiological biomarkers of N-methyl-D-aspartate receptor dysfunction in serine racemase knockout mice

35. Multimodal Computational Modeling of Visual Object Recognition Deficits but Intact Repetition Priming in Schizophrenia

36. Clinical Efficacy and Target Engagement of Glutamatergic Drugs: Placebo-Controlled RCTs of Pomaglumetad and TS-134 for Reversal of Ketamine-Induced Psychotic Symptoms and PharmacoBOLD in Healthy Volunteers

37. Parcel-guided rTMS for depression

38. Failure to engage the temporoparietal junction/posterior superior temporal sulcus predicts impaired naturalistic social cognition in schizophrenia

39. Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications

40. Neurofilament light interaction with GluN1 modulates neurotransmission and schizophrenia-associated behaviors

41. Seeing the World as it is: Mimicking Veridical Motion Perception in Schizophrenia Using Non-invasive Brain Stimulation in Healthy Participants

42. Developmental trajectory of mismatch negativity and visual event-related potentials in healthy controls: Implications for neurodevelopmental vs. neurodegenerative models of schizophrenia

43. Sensory and cross-network contributions to response inhibition in patients with schizophrenia

44. Rodent Mismatch Negativity/theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia

45. Pupillometer-based neurofeedback cognitive training to improve processing speed and social functioning in individuals at clinical high risk for psychosis

46. Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients

47. Failure to engage the TPJ-pSTS during naturalistic scene processing in schizophrenia

48. Neural and functional correlates of impaired reading ability in schizophrenia

49. Are basic auditory processes involved in source-monitoring deficits in patients with schizophrenia?

50. Deficits and compensation: Attentional control cortical networks in schizophrenia

Catalog

Books, media, physical & digital resources